-
Posted: January 25th, 2023, 3:00pm GMT
Condition: Cholangiocarcinoma
Interventions: Drug: Carrelizumab; Drug: Solfantinib
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
-
Posted: January 12th, 2023, 3:00pm GMT
Conditions: Hepatocellular Carcinoma; Fibrolamellar Hepatocellular Carcinoma; Cholangiocarcinoma, Perihilar; Intrahepatic Cholangiocarcinoma; Metastasis to Liver; Gallbladder Carcinoma
Intervention: Other: ADBoard
Sponsors: Charite University, Berlin, Germany; German Research Center for Artificial Intelligence
Not yet recruiting
-
Posted: February 14th, 2022, 3:00pm GMT
Conditions: Biliary Tract Neoplasms; Pancreatic Carcinoma; Gallbladder Cancer; Pancreatic Head Carcinoma
Intervention: Diagnostic Test: The level of CIN
Sponsors: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Zhongshan Hospital; Ruijin Hospital; Changhai Hospital; Shanghai Changzheng Hospital; Eastern Hepatobiliary Surgery Hospital; First Affiliated Hospital Xi'an Jiaotong University; Jiangsu Provincial People's Hospital; Third Affiliated Hospital, Sun Yat-Sen University; First Affiliated Hospital of Zhejiang University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Second Hospital of Jilin University; West China Hospital; Southwest Hospital, China; Affiliated Hospital of North Sichuan Medical College; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
-
Posted: November 1st, 2021, 2:00pm GMT
Conditions: Non Small Cell Lung Cancer; Gastric Adenocarcinoma; Pancreatic Cancer; Gall Bladder Cancer; Bladder Cancer
Intervention: Diagnostic Test: Oricol Test
Sponsors: Origin Sciences; Royal Devon and Exeter NHS Foundation Trust; Queen Mary University of London
Recruiting
-
Posted: August 11th, 2021, 2:00pm GMT
Conditions: Bile Duct Cancer; Gall Bladder Cancer; Breast Cancer; Neuroendocrine Tumors; Ovarian Cancer; Pancreatic Adenocarcinoma; Soft Tissue Sarcoma; Vulvar Cancer; Prostate Cancer
Interventions: Drug: Atezolizumab; Drug: Tivozanib
Sponsors: University of Florida; Genentech, Inc.; Aveo Oncology Pharmaceuticals
Recruiting
-
Posted: September 23rd, 2020, 2:00pm GMT
Conditions: Biliary Tract Cancer; Cholangiocarcinoma; Gallbladder Cancer; Intrahepatic Cholangiocarcinoma; Perihilar Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma; Hilar Cholangiocarcinoma; Distal Bile Duct Cancer
Intervention: Diagnostic Test: Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
Sponsors: University of Washington; Natera, Inc.; SEngine Precision Medicine, Inc.
Recruiting
-
Posted: April 23rd, 2019, 2:00pm GMT
Conditions: Metastatic Breast Carcinoma; Locally Advanced Breast Cancer; Cancer of Pancreas; Solid Tumor With Intermediate or High HER2 Expression; Salivary Gland Cancer; Gastric Cancer; Endometrial Cancer; Uterine Cancer; Non Small Cell Lung Cancer; Biliary Tract Cancer; Cholangiocarcinoma; Colorectal Cancer; Urothelial Carcinoma; Prostate Cancer
Intervention: Drug: 68GaNOTA-Anti-HER2 VHH1
Sponsors: Universitair Ziekenhuis Brussel; Kom Op Tegen Kanker; Agentschap voor Innovatie door Wetenschap en Technologie, Project Toegepast Biomedisch onderzoek met een primair Maatschappelijke finaliteit.
Recruiting